MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $639K of MaxCyte, Inc.
Sold$639,405
$5.14Price
124,450Shares
−27%Stake
What MXCT did after the filing
- The stock from Wed, Dec 6 close, $5.13
- −3.1%
- S&P 500, same days
- +6.7%
Measured over 30 trading days, to the Jan 22 close.
Traded Mon, Dec 4. Filed Wed, Dec 6, 11:15 AM ET, during the session. Returns use the Dec 6 close and the Jan 22 close. Not investment advice.